Hyperion DeFi, Inc. (NASDAQ:HYPD) Receives Consensus Rating of “Hold” from Brokerages

Shares of Hyperion DeFi, Inc. (NASDAQ:HYPD) have earned an average recommendation of “Hold” from the five brokerages that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $4.5833.

HYPD has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Chardan Capital set a $7.75 target price on Hyperion DeFi and gave the stock a “buy” rating in a report on Wednesday, December 24th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperion DeFi in a report on Wednesday, October 8th. Cantor Fitzgerald assumed coverage on Hyperion DeFi in a report on Tuesday, December 16th. They issued an “overweight” rating and a $4.00 price objective for the company. Finally, Zacks Research raised Hyperion DeFi to a “hold” rating in a research report on Monday.

Insider Activity at Hyperion DeFi

In related news, Director Happy David Walters bought 61,930 shares of the firm’s stock in a transaction on Wednesday, December 17th. The stock was acquired at an average cost of $3.02 per share, for a total transaction of $187,028.60. Following the purchase, the director owned 111,930 shares in the company, valued at approximately $338,028.60. This represents a 123.86% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ellen R. Strahlman purchased 19,702 shares of the stock in a transaction dated Thursday, December 18th. The shares were purchased at an average cost of $3.14 per share, for a total transaction of $61,864.28. Following the completion of the acquisition, the director directly owned 95,150 shares in the company, valued at approximately $298,771. This trade represents a 26.11% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 161,254 shares of company stock worth $511,126 over the last quarter. Company insiders own 10.86% of the company’s stock.

Hyperion DeFi Stock Down 3.7%

NASDAQ:HYPD opened at $3.37 on Wednesday. The firm has a market cap of $27.54 million, a P/E ratio of -0.83 and a beta of 2.80. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.25 and a current ratio of 2.25. Hyperion DeFi has a fifty-two week low of $0.85 and a fifty-two week high of $17.99. The firm has a 50-day simple moving average of $4.79 and a two-hundred day simple moving average of $7.60.

Hyperion DeFi (NASDAQ:HYPD) last issued its earnings results on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.36 million for the quarter. Hyperion DeFi had a negative net margin of 62,238.41% and a negative return on equity of 119.59%. Analysts predict that Hyperion DeFi will post -41.6 earnings per share for the current fiscal year.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.